Status:
COMPLETED
Evaluation of Vaginal Self-sampling Diagnostic Performances to Identify Genital Infections
Lead Sponsor:
Hôpital Européen Marseille
Conditions:
Genital Infection
Asymptomatic Infections
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Screening for genital infection (GI), sexually transmitted infection (STI) and asymptomatic carriage of group B streptococcus (GBS) in pregnant women is a common reason for medical appointments. Conve...
Eligibility Criteria
Inclusion
- Women requiring vaginal or cervical classical sampling to screen for genital infections
- Women requiring vaginal or cervical classical sampling to screen for sexually transmitted infections (STI)
- Pregnant women requiring vaginal classical sampling to screeen for Group B streptococcus asymptomatic carriage in the eighth month of pregnancy
- Informed written consent from the patient
Exclusion
- Person subjected to therapeutic limitation decision
- Women with intact hymen
- Active antibiotic or antifungic treatment
- Antiobiotic or antifungic treatment during the 10 days prior to inclusion
Key Trial Info
Start Date :
October 20 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 6 2018
Estimated Enrollment :
1028 Patients enrolled
Trial Details
Trial ID
NCT04039711
Start Date
October 20 2015
End Date
April 6 2018
Last Update
August 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
European Hospital
Marseille, Bouches-du Rhone, France, 13003